Form 4: ICU Medical Director David C. Greenberg Executes Stock Option and Sells Shares

ICU Medical director David C. Greenberg exercised stock options and sold shares on November 27, 2024.

Summary

• On November 27, 2024, David C. Greenberg, a director at ICU Medical Inc., exercised a non-qualified stock option to acquire 972 shares of common stock at a price of $94.68 per share.
• Following the exercise of the option, Mr. Greenberg sold 972 shares of common stock at a price of $158.1103 per share.
• After these transactions, Mr. Greenberg directly owns 5,037 shares of common stock and indirectly owns 500 shares through a trust.
• He also holds 1,942 non-qualified stock options.

Sentiment

Score: 5

Explanation: The document is a neutral report of insider trading activity, with no inherent positive or negative sentiment.

Industry Context

This is a standard Form 4 filing, which is common for corporate insiders who trade company stock. It provides transparency into the transactions of company directors.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The transactions are typical for directors who receive stock options as part of their compensation.

Stakeholder Impact

• The transactions are unlikely to have a significant impact on stakeholders, as they are routine for company directors.

Key Dates

Keywords

ICU Medical, stock options, insider trading, Form 4, David C. Greenberg, share sale, director, equity securities